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Purpose.T ostudytheprotectingeﬀectsofdexamethasoneonthymusofratswithsevereacutepancreatitis(SAP).Methods.TheSAP
rats were randomly assigned to the model group and dexamethasone-treated group, the other normal healthy rats were assigned
to the sham operation group. The rat survival, thymus pathological changes, apoptotic index, as well as expression levels of NF-κB,
P-selectin, Bax, Bcl-2, and Caspase-3 protein of all groups were observed, respectively, at 3 hours, 6 hours, and 12 hours. The
contents of amylase and endotoxin in plasma as well as the contents of TNF-α,P L A 2, and NO in serum were determined. Results.
There was no marked diﬀerence between the model group and treated group in survival. The contents of diﬀerent indexes in blood
of treated group were lower than those of the model group to various degrees at diﬀerent time points. The thymus pathological
score was lower in treated group than in model group at 12 hours.The treated group in Caspase-3 protein expression of thymus
signiﬁcantly exceeded the model group at 12 hours. The apoptotic index was signiﬁcantly higher in treated group than in model
group. Conclusion. Dexamethasone has protecting eﬀects on thymus of SAP rats.
Copyright © 2007 Zhang Xiping et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Acute pancreatitis (AP) especially severe acute pancreatitis
(SAP) is a dangerous acute abdomen among diseases of di-
gestive system. In its early stage, a big amount of inﬂam-
matory mediators will be released and activated to cause
excessive immune response, resulting in cascade inﬂamma-
toryinjuryorinseverecasessystemicinﬂammatoryresponse
syndrome (SIRS) and multiple organ dysfunction syndrome
(MODS) [1–3]. As a basic physiological mechanism of body
to maintain normal morphous and function, apoptosis has
been found in multiple organs in systemic SAP complica-
tions [4–6]. At present, the sound therapeutic eﬀects of large
dose of dexamethasone on SAP has been demonstrated but
further study still should be conducted for its therapeutic
mechanism. There are still few reports on thymus patho-
logical changes during SAP all over the world [7]. In this
experiment, the inﬂammatory mediators in blood, thymus
apoptosis, and protein expression of NF-κB, P-selectin, Bax,
Bcl-2, and Caspase-3 upon the onset of rat SAP have been
studiedtodiscusstheprotectingeﬀectsofdexamethasoneon
SAP complicated thymus injury and its mechanism. The tis-
sue microarray has also been applied to the pathohistological
examination of pancreatitis to improve the study eﬃciency,
which was ﬁrst reported in this article around the world.
2. MATERIALS AND METHODS
2.1. Materials
Clean grade healthy male Sprague-Dawley (SD) rat in 250–
300g of body weight purchased from the Experimen-
tal Animal Center of Medical School, Zhejiang University
(Hangzhou, China). Sodium taurocholate and sodium pen-
tobarbital purchased from Sigma-Aldrich (Mo, USA). Dex-
amethasone injection purchased from Zhejiang Xinchang
(Shaoxing, China). The full automatic biochemical ana-
lyzer was used to determine the plasma amylase level (U/L).
Plasma endotoxin tachypleus amebocyte lysate kit was pur-
chased from Shanghai Yihua Medical Science and Technol-
ogy Corporation (Institute of Medical Analysis in Shanghai,
China),thecalculationunitforcontentisEU/mL.Theserum
nitrogen monoxidum (NO) kit was purchased from Nanjing
Jiancheng Bioengineering Research Institute (Shengzhen,
China), the calculation unit is μmol/L. The TNF-α ELISA
kit was purchased from Jingmei Bioengineering Corporation2 Mediators of Inﬂammation
(Hangzhou,China),thecalculationunitforcontentispg/mL
(ng/L). The serum secretory phospholipase A2 enzyme As-
say ELA kit (PLA2) was purchased from RdD system Ins and
the calculation unit is U/mL. The NF-κB, Bax, Bcl-2, and
P-Selectinantibody were purchased from Santa Cruz Com-
pany (Calif, USA). Caspase-3 antibody was purchased from
NeoMarkers Company (Calif, USA), DNA nick in situ end-
labeling (TUNEL) kit purchased from Takara Company. The
above determinations were all operated according to the in-
structions of the kits.
2.2. Methods
2.2.1. Animalgrouping
9 0c l e a ng r a d eh e a l t h ym a l eS Dr a t sw e r ep r e p a r e di n t o
the SAP models via the improved Aho’s method [8]a n d
randomly divided into the model group (45 rats) and
dexamethasone-treated group (45 rats). Another 45 were se-
lected to be the sham operation group. In the next step, the
above groups were randomly divided into the 3 hours, 6
hours, and 12 hours groups with 15 rats in each group. The
dexamethasone-treated group was injected with dexametha-
sone injection via vena caudalis, 0.5mg/100g body weight
and single administration 15 minutes after successful prepa-
ration of SAP model. The sham operation group after receiv-
ing abdomen opening performed pancreas and duodenum
turning over and ﬁnally abdomen closing. The sham opera-
tion group and model group were injected with the saline of
the same volume via vena caudalis 15 minutes after the oper-
ation [9, 10].
2.2.2. Animalmodelpreparation
Fasting but water restraining were imposed on all rat groups
12 hours prior to the operation. The rats were anesthetized
by intraperitoneal injection of 2% sodium pentobarbital
(0.25mL/100g) after which the rats are laid and ﬁxed, and
routine shaving, disinfection, and draping were performed.
Model group: after entering abdomen via median epigas-
trium incision, conﬁrmed the bile-pancreatic duct and hep-
atichiluscommonhepaticduct,disclosedthepancreas,iden-
tiﬁed the duodenal papilla inside the duodenum duct wall,
and then used a No. 5 needle to drill a hole in the mesen-
terium avascular area. After inserting a segmental eqidural
catheter into the duodenum cavity via the hole, inserted into
the bile-pancreatic duct toward the direction of papilla in
a retrograde way, used the microvascular clamp to nip the
catheter head temporarily and meanwhile used another mi-
crovascular clamp to temporarily occlude the common hep-
atic duct at the conﬂuence of hepatic duct. After connect-
ing the eqidural catheter end with the transfusion converter,
transfused 3.5% sodium taurocholate 0.1mL/100g by retro-
grade transfusion via the microinjection pump at the speed
of 0.2mL/min. Stayed for 4 minutes after injection and re-
moved the microvascular clamp and epidural catheter. After
checking for bile leakage, sutured the hole in the duodenum
lateral wall. Used the disinfected cotton ball to absorb up the
Table 1: Pathological score standard of thymus.
Pathological
score
Comparison
ofcortex
and medulla
thickness
Countof
epithelial cell
withnecrosis
in cortex
Countof
epithelial cell
withvacuole
degeneration
in medulla
1
Cortex is
thicker or
thinner
than or as
thick as
medulla.
1–3
1.5 1–3 1–3
24 – 1 0
2.5 4–10 4–5
3 >10
3.5 >10 >5
4 Flaky
necrosis
4.5 Flaky
necrosis >5
anesthesia on the abdominal cavity and close the abdomen
[8].
2.2.3. NF-κB,P-selectin,Bax,Bcl-2,and
Caspase-3proteinexpression
Applied tissue microarrays to prepare thymus microar-
ray sections; adopted streptavidin peroxidase (SP) method
for immunohistochemical staining; observed the NF-κB, P-
selectin, Bax, Bcl-2, and Caspase-3 protein expression of thy-
musunderlightmicroscope,respectively,andcarriedoutthe
comprehensive assessment according to the positive cell per-
centage: positive cell count < 10% means (−); positive cell
count 10–20% means (+); positive cell count 20–50% means
(++); positive cell count >50% means (+++) [9].
2.2.4. Apoptoticindex
Applied the tissue microarrays to prepare the thymus mi-
croarray sections; Adopted DNA nick in situ end-labeling
(TUNEL) technology for staining. Observed the thymus
apoptotic cells and calculated apoptotic index, respectively.
The TUNEL staining technique was applied to observe the
changes of thymus apoptotic cells and the apoptotic indexes
were calculated. Apoptotic index = apoptotic cell count/total
cell count × 100% [9].
2.2.5. Pathologicalscorestandardofthymus
There was no pathological score standard of thymus around
world. Therefore, we have made a quantitative scoring stan-
dard according to the thymus pathological changes of diﬀer-
ent experimental groups, see Table 1.Zhang Xiping et al. 3
2.3. Observationindexes
2.3.1. Survival
Examined the rat mortality at 3 hours, 6 hours, and 12
hours after operation and calculated the survival, observed
the gross changes of thymus.
2.3.2. Pathologicalchanges
After mercy killing, rats anesthetized by sodium pentobarbi-
tal in batches, collected the thymus and ﬁxed them accord-
ing to the related requirements, observed the pathological
changes of thymus after HE staining, and performed thymus
pathological score according to the self made standards see
Table 1.
2.3.3. Differentindexesinblood
The contents of plasma amylase and endotoxin, serum NO,
TNF-α,a n dP L A 2 were determined via blood sampling from
heart.
2.3.4. Differentproteinsexpressionandapoptoticindex
To observe NF-κB, P-selectin, Bax, Bcl-2, and Caspase-3 pro-
tein expression and apoptotic index of thymus.
2.4. Statisticalmethods
The statistical analysis was conducted to the arranged ex-
perimental results by applying the SPSS11.5 software. The
Kruskal-Wallis test or variance analysis (only applied to
PLA2)wasapplied tothethreegroupcomparison. TheBonf-
feroni test was also applied to comparison. There are statisti-
cal signiﬁcances when P < .05.
3. RESULTS
3.1. Survival
Model group: mortality, respectively, was 0% (0/15), 0%
(0/15), and 13.33% (2/15) at 3 hours, 6 hours, and 12 hours
while survival was 86.67% all along. The sham operation
group and dexamethasone-treated group survived at all time
points with 100% survival while there was no marked diﬀer-
ence between the model group and dexamethasone-treated
group (P > .05) [8–10].
3.2. Comparisonofplasmaamylasecontent
The model group and dexamethasone-treated group sig-
niﬁcantly exceeded the sham operation group at all time
points (P < .001). No marked diﬀerence between the
dexamethasone-treated groupand model group at 3 hours
and6hours(P >.05).Thedexamethasone-treatedgroupwas
signiﬁcantly less than the model group at 12 hours (P < .01),
see Table 2.
3.3. Comparisonofplasmaendotoxincontent
The model group and dexamethasone-treated group sig-
niﬁcantly exceeded the sham operation group at all time
points (P < .001). No marked diﬀerence between the
dexamethasone-treated group and model group at 3 hours
(P > .05). The dexamethasone-treated group was signiﬁ-
cantly less than the model group at 6 hours and 12 hours
(P < .01), see Table 2.
3.4. ComparisonofserumNOcontent
The model group and dexamethasone-treated group signiﬁ-
cantly exceeded the sham operation group at all time points
(P < .001). The dexamethasone-treated group was signiﬁ-
cantly less than the model group at 3 hours and 12 hours
(P < .01), see Table 2.
3.5. ComparisonofserumTNF-αcontent
The model group and dexamethasone-treated group sig-
niﬁcantly exceeded the sham operation group at all time
points (P < .001). No marked diﬀerence between the
dexamethasone-treated group and model group at 3 hours
(P > .05). The dexamethasone-treated group was signiﬁ-
cantly less than the model group at 6 hours and 12 hours
(P < .05), see Table 2.
3.6. ComparisonofserumPLA2 content
The model group and dexamethasone-treated group signiﬁ-
cantly exceeded the sham operation group at all time points
(P < .001). The dexamethasone-treated group was signiﬁ-
cantly less than the model group at all time points (P < .001),
see Table 3.
3.7. Pathologicalchangesofthymusunder
lightmicroscopeofallgroups
3.7.1. Shamoperationgroup
Inshamoperationgroup,histologicalﬁndingsofthymusat3
hours,6hours,and12hoursareconsistent,thymusstructure
is normal, boundary between cortex and medulla is clear,
cortex/medulla thickness ratio is around 2 ∼1:1 ,l o b u l e
visible, envelope is intact, epithelial cell is with “starry sky”
changes scattered in cortex, condensed deep purple-blue cell
nucleus; many slightly stained epithelial reticular cells in star
shapeandwithmultipleprotuberances,withbignucleusand
rich kytoplasm in medulla; medulla structure is more loose
than cortex, few epithelial cell nucleus slightly stained, and
some epithelial cell “vacuole like”.
3.7.2. Modelgroup
In model group, thymus cortex gradually thinned at 3 hours,
6 hours, and 12 hours, “starry sky” like epithelial cells with
fragmented nucleus, fewer lymphocytes, slightly stained ep-
ithelial cell nucleus in medulla, and more chromatin-losing
c e l l s“ v a c u o l el i k e ”t h a ni nn o r m a lg r o u p .4 Mediators of Inﬂammation
Table 2: Comparison of contents of diﬀerent indexes in blood (M(QR)).
Groups index
Sham operation Model Dexamethasone-treated group
3h 6h 12h 3h 6h 12h 3h 6h 12h
Amylase (U/L) 2038
(346)
2117
(324)
1725
(434)
7423
(2275)
8149
(1540)
9195
(1298)
6739
(2310)
7839
(2258)
7791
(1863)
Endotoxin (EU/mL) 0.015
(0.007)
0.015
(0.007)
0.016
(0.005)
0.035
(0.017)
0.055
(0.025)
0.059
(0.020)
0.030
(0.014)
0.040
(0.012)
0.042
(0.018)
NO (μmol/L) 10.0
(12.5)
15.0
(7.5)
15.0
(10.0)
72.5
(17.5)
62.5
(27.5)
70.0
(13.75)
50.0
(20)
60.0
(12.5)
45.0
(17.5)
TNF-α (ng/L) 3.30
(3.60)
4.90
(2.60)
3.70
(2.30)
46.13
(37.95)
77.54
(42.16)
67.30
(32.13)
38.40
(26.60)
58.30
(26.40)
38.70
(28.5)
Table 3: Comparison of PLA2 in serum (X ±S).
Groups 3h 6h 12h
Sham operation
group
18.70 ±4.40 16.70 ±3.83 18.52 ±11.31
Model group 103.69 ±20.82 119.85 ±17.74 121.29 ±17.01
Dexamethasone-
treated group
53.96 ±15.40 67.75 ± 27.95 65.27 ±26.21
Table 4: Comparison of pathological score of the thymus (M(QR)).
Groups 3h 6h 12h
Sham operation group 0.0 (1.0) 0.0 (2.0) 0.0 (1.0)
Model group 2.0 (0.0) 2.5 (2.0) 3.0 (1.5)
Dexamethasone-treated group 2.0 (1.5) 2.5 (1.0) 2.5 (0.5)
3.7.3. Dexamethasone-treatedgroup
In treated group, cortex slightly thinned, more “starry sky”
like cortex epithelial cells than in normal group, much less
lymphocytes, and many “vacuole like” epithelial cells in
medulla.
3.8. Comparisonofthymuspathological
scoresofallgroups
T h es c o r e sw e r eh i g h e ri nm o d e lg r o u pa n dt r e a t e dg r o u p
than in sham operation groupat diﬀerent time points (P <
.001). The score was lower in treated group than in model
group at 12 hours (P < .05), see Table 4.
3.9. Changesofdifferentproteinsexpression
The expression of NF-κB, P-selectin, Bax, and Bcl-2 in thy-
mus was negative in all groups at diﬀerent time points, see
Figure 1.
Figure 1: Treated group: 12 hours; NF-κB × 200.
3.10. Comparisonofthymusapoptosis
countsofallgroups
Lymphocytes were apoptotic cells of thymus. In sham op-
eration group, apoptotic cells were found, respectively, in 2
and 1 rat at 6 hours and 12 hours, and the apoptotic index
was between 10 per 10000 and 24 per 10000 as shown in Fig-
ures 2 and 3. In model group, apoptotic cells were found in
2 rats at 12 hours, and the apoptotic index was between 6
per 10000 and 8 per 10000 as shown in Figure 4.I nt r e a t e d
g r o u p ,a p o p t o t i cc e l l sw e r ef o u n d ,r e s p e c t i v e l y ,i n6 ,9 ,a n d
8 rats at 3 hours, 6 hours, and 12 hours, and the apoptotic
index was between 2 per 10000 and 76 per 10000 as shown
in Figures 5 and 6. The counts were higher in treated group
than in sham operation group and model group at diﬀerent
time points (P < .05). There was no marked diﬀerence be-
tween model group and sham operation group (P > .05), see
Table 5.
3.11. ComparisionofCaspase-3proteinofthymusof
allgroups
The dexamethasone-treated group signiﬁcantly exceeded the
s h a mo p e r a t i o ng r o u pa td i ﬀerent time points (P < .01).
The model group signiﬁcantly exceeded the sham operation
group at 3 hours and 6 hours (P < .05). The dexamethasone-
treated group signiﬁcantly exceeded the model group at 12
hours (P < .05), see Tables 6 and 7, and Figures 7–10.Zhang Xiping et al. 5
Figure 2: Sham operation group: 6 hours; Tunel × 200.
Figure 3: Sham operation group: 12 hours; Tunel × 200.
3.12. Correlationanalysis
The amylase of the model group was positively correlated
with PLA2 at 3 hours (P < .05). The amylase of the model
group was positively correlated with NO at 6 hours (P < .05).
The NO of the dexamethasone-treated group was positively
correlated with PLA2 (P < .05) and apoptotic indexes were
negatively correlated with PLA2 at 3 hours (P < .05). The
TNF-αcontentofthedexamethasone-treatedgroupwaspos-
itively correlated with PLA2 at 6 hours (P < .05). Apoptotic
indexes of the dexamethasone-treated group were negatively
correlated with PLA2 at 12 hours (P < .05).
4. DISCUSSIONS
When SAP occurs, pancreatins such as trypsin, pancrelipase,
and amylopsin will be activated and excessively released [11],
resulting in necrosis of pancreas and tissues around it. The
absorbed necrotic tissue and bulk toxic substances will cause
severe systemic inﬂammatory reaction. The inﬂammatory
mediators are TNF-α,P L A 2, NO, endotoxin, and so on. As
one of the ﬁnal common mediators in cascade reaction of in-
ﬂammatory mediators [12], NO can be regarded as a study
index for the changes of SAP state. TNF-α which is an im-
portant cytokine participates in SAP inﬂammatory cascade
reaction [13, 14]. In SAP cases, endotoxin may reach tissues
such as lung and liver due to intestinal mucosa damage [15].
The abnormal release and activation of PLA2 are closely re-
Figure 4: Model group: 12 hours; Tunel × 200.
Figure 5: Treated group: 12 hours; Tunel × 200.
Table 5: Comparison of apoptosis index of the thymus (M(QR)).
Group 3h 6h 12h
Sham operation group 0.00 (0.00) 0.00 (0.00) 0.00 (0.00)
Model group 0.00 (0.00) 0.00 (0.00) 0.00 (0.00)
Dexamethasone-treated
group 0.00 (0.06) 0.06 (0.12) 0.02 (0.30)
lated with SAP severity, and the PLA2 inhibitor can improve
the pathological changes of SAP [16, 17]. The activation of
NF-κB, which is a transcription factor participating in the
regulation of inﬂammatory molecule expression and regu-
latesinﬂammatorymediatorexpression,isthekeyinitialstep
of inﬂammatory reaction [18, 19]. P-Selectin is a member of
the family of cell adhesion molecule and is expressed in most
architectonic blood vessels of the normal human body. How-
ever, the content is very low and the expression can be signif-
icantly increased when in acute inﬂammation [20, 21]. It is
also an important indicator of inﬂammation [20, 22]. This
study found that NF-κB and P-selectin were negative in all
groups and showed that they were not related to the inﬂam-
matory reaction of thymus in SAP rats.
In this experiment, the plasma endotoxin content and
contents of NO, TNF-α,a n dP L A 2 in serum were all lower
i nt r e a t e dg r o u pt h a ni nm o d e lg r o u p ,a n dw e r en e g a t i v e l y
correlated with thymus pathological changes, demonstrating6 Mediators of Inﬂammation
Figure 6: Treated group: 12 hours; Tunel × 200.
Table 6: Expression of Caspase-3 protein of the thymus.
Group Time (h) Cases Pathologic grade
− + ++ +++
Sham operation group
31 5
61 5 1 5
12 15 15
Model group
31 5 1 0 5
61 5 1 0 5
12 13 10 3
Treated group
31 5 8 7
61 5 6 9
12 15 5 10
Table 7:ComparisionofCaspase-3proteinofthethymus(M(QR)).
Group 3h 6h 12h
Sham operation group 0.00 (0.00) 0.00 (0.00) 0.00 (0.00)
Model group 0.00 (1.00) 0.00 (1.00) 0.00 (0.00)
Treated group 0.00 (1.00) 1.00 (1.00) 1.00 (1.00)
a close relation between SAP severity and content of inﬂam-
matory mediators.
Playing an important role in the onset, progression, and
prognosis of AP, apoptosis can be categorized into gene-
regulated and nongene-regulated apoptosis. There are direct
and indirect gene regulations. Bax and Bcl-2 are two impor-
tant components of the apoptosis regulation system, but in
this experiment, Bax and Bcl-2 were negative and not irrel-
evant to apoptosis of thymus. Caspase-3 is one of the im-
portant proteases which can induce apoptosis and is also the
ﬁnal eﬀect factor of the caspase cascade eﬀect which is in-
volved in apoptosis, and moreover it is at the core position in
theprocessofcuttingproteasecascade.Caspase-3isamarker
of apoptosis and it is also the performer of apoptosis. It can
destroy a variety of protease complex in cells with the diges-
tive way and activate intranuclear nuclease to cause the DNA
schizolysis form the DNA fragments, to undermine cell cal-
cium pump function, to lead to the situation of intracellu-
Figure 7: Sham operation group: 12 hours; Caspase-3 × 200.
Figure 8: Model group: 12 hours; Caspase-3 × 200.
lar calcium overload, and so on [23, 24]. Inhibiting Caspase-
3 activity can reduce the occurrence possibility of apoptosis
[25].Inthisstudy,wefoundthatthelevelofthymusCaspase-
3 protein expression in the treated group was signiﬁcantly
greater than that of the model group at 12 hours. It is shown
that the role of dexamethasone inducing thymus apoptosis
may be relevant to expression of Caspase-3 protein in SAP.
In addition to be signiﬁcant in inducing the indirect gene
regulation of apoptosis, inﬂammatory mediators are impor-
tant apoptosis participants during AP and their roles are
nonneglectable. These cytoactive molecules are TNF-α,T G F ,
IL,NO,OFR,andsoon[26–30].Inthisexperiment,thecon-
tent of inﬂammatory mediators was lower in treated group
than in model group, and the apoptotic index was higher in
treated group than in model group indicating that apoptosis
canbepromotedbyreducingtheexpressionofinﬂammatory
mediators.
Thymus as an important immunoregulation organ plays
an important role in SIRS and MODS due to SAP. In this
experiment, the expression of inﬂammatory mediators was
lower in treated group than in model group, consistent with
the pathological severity of thymus and negatively corre-
lated with thymus apoptosis count, which demonstrated the
protecting eﬀects of apoptosis on thymus. Therefore, the
author believes that just like those ﬁndings in SAP pan-
creas [31, 32] study, when necrosis and apoptosis coexist,
the protecting eﬀect can be achieved by inducing apoptosisZhang Xiping et al. 7
Figure 9: Treated group: 3 hours; Caspase-3 × 200.
Figure 10: Treated group: 6 hours; Caspase-3 × 200.
if necrosis prevails. Both necrosis and apoptosis are death
modes of injured cells [33]. What makes apoptosis substan-
tially diﬀerent from necrosis is that apoptosis will not release
the harmful substance in lysosome or cause intense inﬂam-
matory reaction [34].
In AP/SAP, glucocorticoid (represented by dexametha-
sone) mainly inhibits the generation and/or eﬀect of inﬂam-
matory mediators, enhances physical stress, improves micro-
circulation, alleviates endotoxemia, eliminates free radicals,
and inhibits NO and NF-κB[ 35–37]. Dong et al. [38, 39]
have found early that large dose of dexamethasone can more
eﬀectively treat SAP. In this experiment, large dose of dex-
amethasone has been administered. At present, the capacity
of dexamethasone to induce thymus apoptosis has been con-
ﬁrmed [40–43]. According to the study on SIRS and MODS,
thymus apoptosis or proliferation will cause immune func-
tion disorder [44]. We believe that the excessive immune re-
sponse can be depressed by reducing immunocytes to inhibit
the release of inﬂammatory mediators. Therefore, SAP com-
plications can be alleviated by dexamethasone through in-
duction of thymus apoptosis.
The method of sodium taurocholate injection through
biliopancreatic duct to induce SAP rat model was ﬁrst re-
ported by Aho et al. [45]. It is a classic model preparation
methodextensivelyappliedbytheworldresearchers.Wehave
found in practice [38] that ideal SAP rat models can be in-
duced by 3.5% sodium taurocholate injected by minipump
after retrograde puncturation of segmental eqidural cathete
viaduodenalpapilla.Thismethodfeaturesmildwound,con-
venient operation, and high achievement ratio.
It was found in this study that the rat survival was
higher in treated group than in model group, the patho-
logical changes were milder in treated group than in model
group, and the apoptotic index was higher in treated group
thanin model group(P <.05), which demonstrates that dex-
amethasone can promote the apoptosis of thymus and pro-
tect it. It was found in the experiment that the thymus apop-
tosis count of treated group was positively correlated with
PLA2 and the expression of amylase, NO, and TNF-α was
alsopositivelycorrelatedwithPLA2,whichsuggeststhatdex-
amethasone can alleviate thymus injury by lowering PLA2
content in SAP circulatory blood, inhibiting the secretion of
amylase, and promoting the generation of cytokines such as
TNF-α a n dN Oa sw e l la st h y m u sa p o p t o s i s .T h ee n d o t o x i n
was lower in treated group than model group, which demon-
strates that dexamethasone might inhibit the excessive sys-
temic inﬂammatory reaction and indirectly induce apopto-
sis to improve the thymus injury of SAP rats. It can be ﬁg-
ured out that dexamethasone did not induce thymus apop-
tosis through regulating NF-κB, P-selectin, Bax, and Bcl-2 of
thymussincetheirexpressionswerenegativeatdiﬀerenttime
points.
Tissue microarray, featuring high-throughput, multiple
samples as well as being economical and time saving, error
reduction, convenient for empirical control design, and ca-
pable for combining with other biological technologies [46],
has been extensively applied to ﬁelds such as oncopathol-
ogy and drug study [47–49] .T h et i s s u em i c r o a r r a yh a sb e e n
used for the pathological examination of pancreatitis study
for the ﬁrst time in this experiment. We have used a tissue
microarray section machine to make holes 2.0mm in diam-
eter on receptor paraﬃn block, and we have combined su-
persensitive SP immunohistochemical method, TUNEL, and
othertechniquestodeterminetheproteinexpressionsofBax,
Bcl-2, and NF-κBg e n e so ft h y m u sc e l l sa sw e l la sa p o p t o s i s
counts. The satisfying results demonstrate that tissue sam-
ple of 2.0mm diameter can lead to reliable and highly rep-
resentative experimental results. It is also energy-, time-, and
reagent-saving, convenient for control, and so on.
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